Abstract
When Thy-1− cell lines derived from different Thy-1+ murine thymic lymphomas are analyzed by complementation analysis, most fall into the “A” complementation class. A possible explanation for this result is that the Class A phenotype is due to a mutation in a gene on the X chromosome. To test this idea, selection for 6-thioguanine resistance was carried out on Thy-1+ hybrid cell lines between complementary Class A and Class C Thy-1− mutant cell lines. In some hybrid clones, there was complete concordance between 6-thioguanine resistance and a change of the phenotype of the hybrid from Thy-1+ to Thy-1−. Detailed study of one of these hybrid clones showed that 6-thioguanine resistance was accompanied by loss of hypoxanthine guanine phosphoribosyltransferase activity and that the Thy-1− phenotype was attributable to loss of the gene complementing the Class A Thy-1− mutation.
Other hybrid clones, however, had some thioguanine resistant lines which remained Thy-1+. The degree of concordance was a characteristic of the particular hybrid clone examined and subclones which showed complete concordance could be derived from clones showing incomplete concordance. The variability in the degree of concordance between 6-thioguanine resistance and the Thy-1− phenotype in different hybrid cell lines was also seen among individual hybrid clones isolated from a fusion between a Class A mutant and normal spleen cell blasts.
We conclude from these results that the basis of the Class A Thy-1− phenotype is genetic, but given the variability in the degree of linkage observed, we cannot determine whether the gene determining the Class A mutant phenotype is X-linked in the normal situation.
Similar content being viewed by others
References
Arce-Gomez, B., Jones, E., Barnstable, C., Solomon, E., and Bodmer, W.: The genetic control of HLA-A and B antigens in somatic cell hybrids: Requirement for B2 microglobulin.Tissue Antigens 11: 96–112, 1978
Atkinson, M. and Murray, A.: Inhibition of purine phosphoribosyl-transferase of Ehrlich ascites-tumor cells by 6-mercaptopurine.Biochem. J. 94: 64–70, 1965
Chapman, A., Trowbridge, I., Hyman, R., and Kornfeld, S.: Structure of the lipid-linked oligosaccharides that accumulate in class E Thy-1-negative mutant lymphomas.Cell 17: 509–515, 1979
Chapman, V. and Shows, T.: Somatic cell genetic evidence for X-chromosome linkage of three enzymes in the mouse.Nature 259: 665–667, 1976
Fenwick, R. and Caskey, C.: Mutant Chinese hamster cells with a thermosensitive hypoxanthineguanine phosphoribosyltransferase.Cell 5: 115–122, 1975
Horibata, K. and Harris, A.: Mouse myelomas and lymphomas in culture.Exp. Cell Res. 60: 61–77, 1970
Hyman, R.: Studies on surface antigen variants. Isolation of two complementary variants for Thy 1.2.J. Natl. Cancer Inst. 50: 415–422, 1973
Hyman, R. and Stallings, V.: Complementation patterns of Thy-1 variants and evidence that antigen-loss variants “pre-exist” in the parental population.J. Natl. Cancer Inst. 52: 429–436, 1974
Hyman, R. and Stallings, V.: Characterization of a TL− variant of a homozygous TL+ mouse lymphoma.Immunogenetics 3: 75–84, 1976
Hyman, R. and Stallings, V.: Evidence for a gene extinguishing cell-surface expression of the Thy-1 antigen.Immunogenetics 6: 447–458, 1978
Hyman, R. and Trowbridge, L.: Analysis of lymphocyte surface antigen expression by the use of variant cell lines.Cold Spring Harbor Symp. Quant. Biol. 41: 407–415, 1977
Hyman, R. and Trowbridge, I.: Analysis of the Biosynthesis of T25 (Thy-1) in mutant lymphoma cells: A model for plasma membrane glycoprotein biosynthesis.In B. Clarkson, P. A. Marks and J. E. Till (eds.):Differentiation of Normal and Neoplastic Hematopoietic Cells, pp. 741–754, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1978
Old, L., Stockert, E., Boyse, E., and Kim, J.: Antigenic modulation. Loss of TL antigens from cells exposed to TL antibody. Study of the phenomenonin vitro. J. Exp. Med.127: 523–539, 1968
Pious, D. and Soderland, C.: HLA variants of cultured human lymphoid cells: Evidence for mutational origin and estimation of mutation rate.Science 197: 769–771, 1977
Pious, D., Hawley, P., and Forrest, L.: Isolation and characterization of HL-A variants in cultured human lymphoid cells.Proc. Natl. Acad. Sci. U.S.A. 70: 1397–1400, 1973
Pious, D., Soderland, C., and Gladstone, P.: Induction of HLA mutations by chemical mutagens in human lymphoid cells.Immunogenetics 4: 437–448, 1977
Rajan, T.: H-2 antigen variants in a cultured heterozygous mouse leukemia cell line.Immunogenetics 4: 105–116, 1977
Rajan, T. and Flores, C.: H-2 antigen variants in a cultured heterozygous mouse leukemia cell line III. Effect of selection against a D-end gene.Immunogenetics 5: 585–596, 1977
Siminovitch, L.: On the nature of hereditable variation in cultured somatic cells.Cell 7: 1–11, 1976
Trowbridge, I.: Mitogenic properties of pea lectin and its chemical derivatives.Proc. Natl. Acad. Sci. U.S.A. 70: 3650–3654, 1973
Trowbridge, I. and Hyman, R.: Abnormal lipid-linked oligosaccharides in class E Thy-1-negative mutant lymphomas.Cell 17: 503–508, 1979
Trowbridge, I., Hyman, R., and Mazauskas, C. The synthesis and properties of T25 glycoprotein in Thy-1-negative mutant lymphoma cells.Cell 14: 21–32, 1978
Wood, A., Becker, M., and Seegmiller, J.: Purine nucleotide synthesis in lymphoblasts cultured from normal subjects and a patient with Lesh-Nyhan Syndrome.Biochem. Genetics 9: 261–274, 1973
Worton, R., Ho, C., and Duff, C.: Chromosome stability in CHO cells.Somatic Cell Genet. 3: 27–45, 1977
Zwerner, R. and Acton, R.: Growth properties and alloantigenic expression of murine lymphoblastoid cell lines.J. Exp. Med. 142: 378–390, 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hyman, R., Cunningham, K. & Stallings, V. Evidence for a genetic basis for the class A Thy-1− defect. Immunogenetics 10, 261–271 (1980). https://doi.org/10.1007/BF01561574
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01561574